Recently, the Immune Deficiency Foundation (IDF) was invited to try for a grant sponsored by PI CONNECT. The grant would allow the IDF to study the compared effectiveness of antibiotic treatment for patients with immune deficiencies.
This could be an important study, so much so that the IDF even petitioned its community for input before the grant’s September 30th, 2015 deadline.
As they explained in an August 2015 blog post, some of the areas of investigation would include the effects of prolonged antibiotic use. While this type of therapy has been proven to be effective, no studies for primary immunodeficiency disease (PID) patients have been conducted. The possible outcome of this study would address the gastrointestinal symptoms for people with PIDs who are on protracted antibiotic therapies.
A second part of the study would determine the benefits of probiotics for PID patients, as well as for those with Chronic Obstructive Pulmonary Disease (COPD). Scientists will also explore the frequency of infection and GI symptoms for those taking an oral bovine IG, probiotics, and omega-3 fatty acids.
For more information, e-mail [email protected] or call 800-296-4433.
